Arvidson Chiropractic Center Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 379 W Main St, Tilton, NH 03276 Phone: 603-286-2225 Fax: 603-286-9378 |
Dr. Barry Lee Arvidson, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 379 W Main St, Tilton, NH 03276 Phone: 603-286-2225 Fax: 603-286-9378 |
Dr. Tyler Kuntz, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 7 Grange Rd, Tilton, NH 03276 Phone: 603-729-0009 Fax: 603-729-0019 |
Amanda Janine Lajoie, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7 Grange Rd, Tilton, NH 03276 Phone: 603-729-0009 Fax: 603-729-0019 |
Dr. Robert John Nesham, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4 Prospect St, Tilton, NH 03270 Phone: 603-286-3306 Fax: 603-288-8991 |
Awakening Chiropractic, Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 7 Grange Rd, Tilton, NH 03276 Phone: 603-729-0009 |
Jilian Mary Stogniew, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 7 Grange Rd, Unit A, Tilton, NH 03276 Phone: 603-703-1534 |
News Archive
XenoPort announced today that data from clinical trials of its product candidates arbaclofen placarbil and XP13512 (gabapentin enacarbil) will be presented at the Associated Professional Sleep Society meeting in San Antonio, Texas.
In a new project, researchers from LIFE - the Faculty of Life Sciences at the University of Copenhagen - document that the vesicular stomatitis virus (VSV) plays a previously unknown dual role in the prevention of a number of cancers. The new findings show that the virus both kills cancer cells and stops the expression of the molecules which certain types of cancer cells produce to hide from the immune system.
A gene associated with both protection against bacterial infection and excessive blood clotting could offer new insights into treatment strategies for deep-vein thrombosis - the formation of a harmful clot in a deep vein.
MagForce Nanotechnologies AG (FWB:MF6) has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-CancerĀ® therapy.
› Verified 3 days ago